Youcare Pharmaceutical Group , Ltd. EBIT

Youcare Pharmaceutical Group , Ltd. (688658.SS) currently reports a EBIT of $-240M as of June 2026. That compares with $-67M in the prior-year period — down 252.1% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Youcare Pharmaceutical Group , Ltd.'s EBIT history and peer comparisons.

Youcare Pharmaceutical Group , Ltd.'s EBIT decreased from $-67M to $-240M — a 252.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Youcare Pharmaceutical Group , Ltd.'s EBIT of $-240M is lower than the Healthcare sector average of $110B. That is roughly 100.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Youcare Pharmaceutical Group , Ltd. reported $-240M in EBIT as of June 2026. That compares with $-67M in the prior-year period — down 252.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-240M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Youcare Pharmaceutical Group , Ltd., and consider following 688658.SS for alerts when major investors trade the stock.